Myelophthisic Anemia in Diffuse Skeletal Metastatic Basosquamous Cell Carcinoma
Annals of Internal Medicine: Clinical Cases · 01.11.2026 · 5 (11)
DOI: 10.7326/aimcc.2026.0391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine: Clinical Cases, erschienen am 01.11.2026. Verfasst von Arham M. Siddiqui und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Metastatic basosquamous cell carcinoma (BSC) has a distinctly low rate of metastasis with involvement typically in the lymph nodes. This report is of a BSC possibly originating from a posterior right shoulder wound with diffuse lytic bone metastases, soft tissue densities, and a myelophthisic anemia. Management currently is palliative pembrolizumab and sonidegib combination therapy alongside radiation. Myelophthisic anemia has been reported in basal cell cancer in 6 cases, but no reports of BSC with lytic bone metastasis alongside myelophthisic anemia have been seen at this time, which prompts further investigation for both treatment and detection.
Zitieren
APA
Siddiqui, A. M., Schnautz, R., Manne, R., & Saleh, N. (2026). Myelophthisic Anemia in Diffuse Skeletal Metastatic Basosquamous Cell Carcinoma. Annals of Internal Medicine: Clinical Cases, 5(11). https://doi.org/10.7326/aimcc.2026.0391
Vancouver
Siddiqui AM, Schnautz R, Manne R, Saleh N. Myelophthisic Anemia in Diffuse Skeletal Metastatic Basosquamous Cell Carcinoma. Annals of Internal Medicine: Clinical Cases. 2026;5(11). doi:10.7326/aimcc.2026.0391
BibTeX
@article{Siddiqui2026,
author = {Siddiqui, Arham M. and Schnautz, Ryan and Manne, Rahul and Saleh, Nael},
title = {Myelophthisic Anemia in Diffuse Skeletal Metastatic Basosquamous Cell Carcinoma},
journal = {Annals of Internal Medicine: Clinical Cases},
year = {2026},
volume = {5},
number = {11},
doi = {10.7326/aimcc.2026.0391}
}
EUVIMED